Matches in SemOpenAlex for { <https://semopenalex.org/work/W3031195177> ?p ?o ?g. }
Showing items 1 to 70 of
70
with 100 items per page.
- W3031195177 endingPage "443" @default.
- W3031195177 startingPage "439" @default.
- W3031195177 abstract "ObjectiveTo compare the effect of ticagrelor and clopidogrel on platelet functions and inflammation factor in patients with acute coronary syndrome(ACS) after PCI.Methods180 patients with ACS who taken PCI were chosen and randomly divided into the observation group and the control group(90 cases in each group). All patients of the two groups were given conventional treatment, and the control group received clopidogrel treatment on the basis of routine therapy preoperation and postoperation, while the observation group received clopidogrel treatment on the basis of the control group treatment.Before treatment and 24 h, 7 d, 28 d after treatment, the C-reactive protein(CRP), interleukin 6(IL-6), tumor necrosis factor alpha(TNF-α), myeloperoxidase(MPO), soluble CD40 receptor(sCD40L), platelet maximum aggregation rate(MPAR) and P2Y12 response unit(PRU) in the two groups were recorded and compared, as well as the main cerebrovascular events after six months follow-up.ResultsIn the two groups before treatment, MPAR and PRU had no statistically significant differences(t=0.41, 0.19, all P>0.05).24h, 7d and 28d after operation, MPAR and PRU were significantly decreased compared with before treatment(t≥2.09, all P 0.05).24h after treatment, CRP, sCD40L, IL-6 and TNF-α in the two groups all significantly increased(all P<0.05), and then decreased.24h, 7d, 28d after treatment, DCRP, sCD40L, IL-6 and TNF-α in the observation group were all significantly lower than those in the control group (t=60.79, 50.30, 27.95, 12.98, 40.29, 16.73, 15.03, 7.30, all P<0.05). And, the incidence rate of cardiovascular adverse events of the observation group was 2.22%, which was significantly lower than 10.00% of the control group(χ2=5.714, P<0.05).ConclusionCompared with clopidogrel, using ticagrelor to treat ACS patients after PCI has better antiplatelet aggregation and inflammation effects, which can reduce the incidence of cardiovascular adverse events.Key words: Coronary artery disease; Ticagrelor; Blood platelets; Chemokines" @default.
- W3031195177 created "2020-06-05" @default.
- W3031195177 creator A5013107472 @default.
- W3031195177 date "2017-02-01" @default.
- W3031195177 modified "2023-10-08" @default.
- W3031195177 title "Comparison of the effect of ticagrelor and clopidogrel on platelet functions and inflammation factor in patients with acute coronary syndrome after PCI" @default.
- W3031195177 doi "https://doi.org/10.3760/cma.j.issn.1008-6706.2017.03.030" @default.
- W3031195177 hasPublicationYear "2017" @default.
- W3031195177 type Work @default.
- W3031195177 sameAs 3031195177 @default.
- W3031195177 citedByCount "0" @default.
- W3031195177 crossrefType "journal-article" @default.
- W3031195177 hasAuthorship W3031195177A5013107472 @default.
- W3031195177 hasConcept C126322002 @default.
- W3031195177 hasConcept C17991360 @default.
- W3031195177 hasConcept C203565725 @default.
- W3031195177 hasConcept C2776914184 @default.
- W3031195177 hasConcept C2777628954 @default.
- W3031195177 hasConcept C2777698277 @default.
- W3031195177 hasConcept C2777849778 @default.
- W3031195177 hasConcept C2780890252 @default.
- W3031195177 hasConcept C45393284 @default.
- W3031195177 hasConcept C500558357 @default.
- W3031195177 hasConcept C71924100 @default.
- W3031195177 hasConcept C89560881 @default.
- W3031195177 hasConcept C90924648 @default.
- W3031195177 hasConceptScore W3031195177C126322002 @default.
- W3031195177 hasConceptScore W3031195177C17991360 @default.
- W3031195177 hasConceptScore W3031195177C203565725 @default.
- W3031195177 hasConceptScore W3031195177C2776914184 @default.
- W3031195177 hasConceptScore W3031195177C2777628954 @default.
- W3031195177 hasConceptScore W3031195177C2777698277 @default.
- W3031195177 hasConceptScore W3031195177C2777849778 @default.
- W3031195177 hasConceptScore W3031195177C2780890252 @default.
- W3031195177 hasConceptScore W3031195177C45393284 @default.
- W3031195177 hasConceptScore W3031195177C500558357 @default.
- W3031195177 hasConceptScore W3031195177C71924100 @default.
- W3031195177 hasConceptScore W3031195177C89560881 @default.
- W3031195177 hasConceptScore W3031195177C90924648 @default.
- W3031195177 hasIssue "3" @default.
- W3031195177 hasLocation W30311951771 @default.
- W3031195177 hasOpenAccess W3031195177 @default.
- W3031195177 hasPrimaryLocation W30311951771 @default.
- W3031195177 hasRelatedWork W2328010013 @default.
- W3031195177 hasRelatedWork W2345359264 @default.
- W3031195177 hasRelatedWork W2347643127 @default.
- W3031195177 hasRelatedWork W2347667763 @default.
- W3031195177 hasRelatedWork W2348307592 @default.
- W3031195177 hasRelatedWork W2350951647 @default.
- W3031195177 hasRelatedWork W2351982236 @default.
- W3031195177 hasRelatedWork W2362311975 @default.
- W3031195177 hasRelatedWork W2369295022 @default.
- W3031195177 hasRelatedWork W2380099191 @default.
- W3031195177 hasRelatedWork W2380471106 @default.
- W3031195177 hasRelatedWork W2392655103 @default.
- W3031195177 hasRelatedWork W2771215921 @default.
- W3031195177 hasRelatedWork W3006532820 @default.
- W3031195177 hasRelatedWork W3029055379 @default.
- W3031195177 hasRelatedWork W3029514158 @default.
- W3031195177 hasRelatedWork W3029674469 @default.
- W3031195177 hasRelatedWork W3030644174 @default.
- W3031195177 hasRelatedWork W3032002504 @default.
- W3031195177 hasRelatedWork W3195422364 @default.
- W3031195177 hasVolume "24" @default.
- W3031195177 isParatext "false" @default.
- W3031195177 isRetracted "false" @default.
- W3031195177 magId "3031195177" @default.
- W3031195177 workType "article" @default.